Factors associated with severe manifestations of histoplasmosis in AIDS

Clinical Infectious Diseases

Volumn 30, Issue 6, 2000, Pages 877-881

  Wheat, L Joseph ^a,d   Chetchotisakd, Ploenchan ^b   Williams, Brian ^c   Connolly, Patricia ^a   Shutt, Kathleen ^e   Hajjeh, Rana ^e  

^a Department of Medicine ^*  (United States)

^b KHON KAEN UNIVERSITY   (Thailand)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; HEMOGLOBIN; THROMBOPLASTIN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; HEMOGLOBIN DETERMINATION; HISTOPLASMA; HISTOPLASMOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RACE DIFFERENCE; RESPIRATORY FAILURE; RISK FACTOR; SHOCK;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHILD; DISEASE OUTBREAKS; FEMALE; HISTOPLASMOSIS; HUMANS; MALE; MIDDLE AGED; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SHOCK;

EID: 0034463108     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313824     Document Type: Article

References (7)

1. Disseminated histoplasmosis in the acquired immune deficiency syndrome: Clinical findings, diagnosis and treatment, and review of the literature
2. Histoplasmosis in the acquired immunodeficiency syndrome
3. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome
4. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome
5. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia
6. A multicenter randomized trial comparing amphotericin B (AmB) and liposomal amphotericin B (AmBisome, LAMB) as induction therapy of disseminated histoplasmosis (DH) in AIDS patients
7. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: Randomized, placebo-controlled, double-blind study